Testing effectiveness (Phase 2)Study completedNCT01982292
What this trial is testing
Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure
Who this might be right for
Chronic Heart Failure
Novartis Pharmaceuticals 321
Showing 20 of 642 results